Laurus Labs
Search results
Granules India is a vertically integrated, high-growth pharmaceutical product manufacturing company based in Hyderabad, India. We manufacture high-quality API, FD, PFI and Speciality Products with a focus on customer centricity.
Granules India is a vertically integrated, high-growth pharmaceutical product manufacturing company based in Hyderabad, India. We manufacture high-quality API, FD, PFI and Speciality Products with a focus on customer centricity.
Granules India is a vertically integrated, high-growth pharmaceutical product manufacturing company based in Hyderabad, India. We manufacture high-quality API, FD, PFI and Speciality Products with a focus on customer centricity.
A Future-Ready Leadership of Vision & Resolve. Granules India is led by a team of seasoned professionals of the pharmaceutical industry. Each leader brings in-depth expertise and a modern outlook to tackle the challenges of today’s dynamic business.
In November 2013, Granules signed a definitive agreement for the acquisition of Auctus Pharma, a leading API manufacturer. The facility has approvals from leading regulatory agencies including the U.S. FDA, EDQM, Health Canada and KFDA The company has products in therapeutic spaces such as antihistaminic, antihypertensive,
Granules US is led by a team of seasoned professionals of the pharmaceutical industry. Each leader brings in-depth expertise and a modern outlook to tackle the challenges of today’s dynamic business.
Granules India is a vertically integrated, high-growth pharmaceutical product manufacturing company based in Hyderabad, India. We manufacture high-quality API, FD, PFI and Speciality Products with a focus on customer centricity.
Granules India is a vertically integrated, high-growth pharmaceutical product manufacturing company based in Hyderabad, India. We manufacture high-quality API, FD, PFI and Speciality Products with a focus on customer centricity.
Granules India announces acquisition of Auctus Pharma and opening of a new R&D Facility Details Granules India Revenue increases 52% to Rs. 266 Cr.; net profit surges 87%
Granules & Greenko ZeroC will develop and promote State-of-the-art Integrated Green Pharmaceutical Zones (GPZ) with first collaboration in Kakinada, Andhra Pradesh. Granules will build a green field facility based on sustainability principles for large scale
